Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis

In the granule exocytosis pathway of cell-mediated cytotoxicity, rapid apoptotic nuclear damage in target cells has been unequivocally linked to granzyme B activity. Direct cleavage and activation of caspase-3 and related proteases by granzyme B have been identified as a central event in apoptosis i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of immunology (1950) 1997-07, Vol.159 (1), p.126-134
Hauptverfasser: Renvoize, C, Roger, R, Moulian, N, Bertoglio, J, Breard, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 134
container_issue 1
container_start_page 126
container_title The Journal of immunology (1950)
container_volume 159
creator Renvoize, C
Roger, R
Moulian, N
Bertoglio, J
Breard, J
description In the granule exocytosis pathway of cell-mediated cytotoxicity, rapid apoptotic nuclear damage in target cells has been unequivocally linked to granzyme B activity. Direct cleavage and activation of caspase-3 and related proteases by granzyme B have been identified as a central event in apoptosis induction by cytotoxic granules. The Bcl-2 oncoprotein has been recently shown to act at the level or upstream of caspase-3 family activation to inhibit apoptosis induced by various stimuli including Fas ligation, an alternative cell-mediated lytic pathway. In this study, we have investigated whether activation of this caspase family by granzyme B, during human NK and lymphokine-activated killer cell granule-mediated apoptosis, could be influenced by Bcl-2 expression. Bcl-2-overexpressing clones were generated from parental K562 and U937 cell lines (K6 and U4 clones, respectively). Bcl-2 expression abrogated early 125I-DNA release and DNA fragmentation, these defects being compensated for by extended incubation times. Cleavage of poly(ADP-ribose) polymerase, a specific caspase-3 family substrate, was detected in parental K562 cells exposed to lymphokine-activated killer effectors but not in K6 targets, indicating that caspase-3 and related proteases function was inhibited by Bcl-2. Functional inhibition of caspase-3 family with benzyloxycarbonyl-Asp-Glu-Val-Asp(OMe) fluoromethylketone led to similar consequences on apoptotic nuclear events as for Bcl-2 expression. Thus, Bcl-2 antagonizes granzyme B-mediated apoptosis by a mechanism that interferes with caspase-3 activity. Finally, Bcl-2 expression or the Asp-Glu-Val-Asp peptide was much less efficient in preventing phosphatidylserine externalization, suggesting that despite impaired nuclear apoptosis, immediate recognition and elimination of Bcl-2-expressing cells by tissue phagocytes should remain partly unaffected.
doi_str_mv 10.4049/jimmunol.159.1.126
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79076919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16028081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-5586e284d6804fa9c25734d82aa44196ebd4a1dd4f92a6db1997fed92cfe16793</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EKkvhBZCQfOKWxfY6TnyECiiiggucrdl4vHHrxMFOuuwb8Zj1tgs9cvJY_uYfz_8T8pqztWRSv7v2w7CMMax5rdd8zYV6Qla8rlmlFFNPyYoxISreqOY5eZHzNWNMMSHPyJkWjEnZrMifD12oBMXfU8KcfRypH-kMaYcz7TCETAOCzXSO1C1jNxcCQmF6v_XHC42OdpAnyFht6JTijKWkDgYfDketfhlgpN--UhgtDYdh6uONH7GConULM1p640PAdD-N7hKMS8BqQOvvH2GK0xyzzy_JMwch46vTeU5-fvr44-Kyuvr--cvF-6uqK5bMVV23CkUrrWqZdKA7UTcbaVsBICXXCrdWArdWOi1A2S3XunFotegcctXozTl5-6Bbdvm1YJ7N4PPxbzBiXLJpNGuU5v8HebG6ZS0voHgAuxRzTujMlPwA6WA4M8cczd8cTcnRcFNyLE1vTurLtpjxr-UU3OP03u_6vU9o8gAhFJqb_X7_KHQHfK-sOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16028081</pqid></control><display><type>article</type><title>Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Renvoize, C ; Roger, R ; Moulian, N ; Bertoglio, J ; Breard, J</creator><creatorcontrib>Renvoize, C ; Roger, R ; Moulian, N ; Bertoglio, J ; Breard, J</creatorcontrib><description>In the granule exocytosis pathway of cell-mediated cytotoxicity, rapid apoptotic nuclear damage in target cells has been unequivocally linked to granzyme B activity. Direct cleavage and activation of caspase-3 and related proteases by granzyme B have been identified as a central event in apoptosis induction by cytotoxic granules. The Bcl-2 oncoprotein has been recently shown to act at the level or upstream of caspase-3 family activation to inhibit apoptosis induced by various stimuli including Fas ligation, an alternative cell-mediated lytic pathway. In this study, we have investigated whether activation of this caspase family by granzyme B, during human NK and lymphokine-activated killer cell granule-mediated apoptosis, could be influenced by Bcl-2 expression. Bcl-2-overexpressing clones were generated from parental K562 and U937 cell lines (K6 and U4 clones, respectively). Bcl-2 expression abrogated early 125I-DNA release and DNA fragmentation, these defects being compensated for by extended incubation times. Cleavage of poly(ADP-ribose) polymerase, a specific caspase-3 family substrate, was detected in parental K562 cells exposed to lymphokine-activated killer effectors but not in K6 targets, indicating that caspase-3 and related proteases function was inhibited by Bcl-2. Functional inhibition of caspase-3 family with benzyloxycarbonyl-Asp-Glu-Val-Asp(OMe) fluoromethylketone led to similar consequences on apoptotic nuclear events as for Bcl-2 expression. Thus, Bcl-2 antagonizes granzyme B-mediated apoptosis by a mechanism that interferes with caspase-3 activity. Finally, Bcl-2 expression or the Asp-Glu-Val-Asp peptide was much less efficient in preventing phosphatidylserine externalization, suggesting that despite impaired nuclear apoptosis, immediate recognition and elimination of Bcl-2-expressing cells by tissue phagocytes should remain partly unaffected.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.159.1.126</identifier><identifier>PMID: 9200447</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Apoptosis - drug effects ; Apoptosis - genetics ; Apoptosis - immunology ; Caspase 3 ; Caspases ; Cell Line ; Cysteine Endopeptidases - genetics ; Cysteine Endopeptidases - immunology ; Cytoplasmic Granules - pathology ; Exocytosis - drug effects ; Gene Expression Regulation ; Gene Transfer Techniques ; Granzymes ; Humans ; Killer Cells, Lymphokine-Activated - immunology ; Killer Cells, Lymphokine-Activated - pathology ; Killer Cells, Natural - immunology ; Killer Cells, Natural - pathology ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - immunology ; Serine Endopeptidases - pharmacology</subject><ispartof>The Journal of immunology (1950), 1997-07, Vol.159 (1), p.126-134</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c404t-5586e284d6804fa9c25734d82aa44196ebd4a1dd4f92a6db1997fed92cfe16793</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9200447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Renvoize, C</creatorcontrib><creatorcontrib>Roger, R</creatorcontrib><creatorcontrib>Moulian, N</creatorcontrib><creatorcontrib>Bertoglio, J</creatorcontrib><creatorcontrib>Breard, J</creatorcontrib><title>Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>In the granule exocytosis pathway of cell-mediated cytotoxicity, rapid apoptotic nuclear damage in target cells has been unequivocally linked to granzyme B activity. Direct cleavage and activation of caspase-3 and related proteases by granzyme B have been identified as a central event in apoptosis induction by cytotoxic granules. The Bcl-2 oncoprotein has been recently shown to act at the level or upstream of caspase-3 family activation to inhibit apoptosis induced by various stimuli including Fas ligation, an alternative cell-mediated lytic pathway. In this study, we have investigated whether activation of this caspase family by granzyme B, during human NK and lymphokine-activated killer cell granule-mediated apoptosis, could be influenced by Bcl-2 expression. Bcl-2-overexpressing clones were generated from parental K562 and U937 cell lines (K6 and U4 clones, respectively). Bcl-2 expression abrogated early 125I-DNA release and DNA fragmentation, these defects being compensated for by extended incubation times. Cleavage of poly(ADP-ribose) polymerase, a specific caspase-3 family substrate, was detected in parental K562 cells exposed to lymphokine-activated killer effectors but not in K6 targets, indicating that caspase-3 and related proteases function was inhibited by Bcl-2. Functional inhibition of caspase-3 family with benzyloxycarbonyl-Asp-Glu-Val-Asp(OMe) fluoromethylketone led to similar consequences on apoptotic nuclear events as for Bcl-2 expression. Thus, Bcl-2 antagonizes granzyme B-mediated apoptosis by a mechanism that interferes with caspase-3 activity. Finally, Bcl-2 expression or the Asp-Glu-Val-Asp peptide was much less efficient in preventing phosphatidylserine externalization, suggesting that despite impaired nuclear apoptosis, immediate recognition and elimination of Bcl-2-expressing cells by tissue phagocytes should remain partly unaffected.</description><subject>Apoptosis - drug effects</subject><subject>Apoptosis - genetics</subject><subject>Apoptosis - immunology</subject><subject>Caspase 3</subject><subject>Caspases</subject><subject>Cell Line</subject><subject>Cysteine Endopeptidases - genetics</subject><subject>Cysteine Endopeptidases - immunology</subject><subject>Cytoplasmic Granules - pathology</subject><subject>Exocytosis - drug effects</subject><subject>Gene Expression Regulation</subject><subject>Gene Transfer Techniques</subject><subject>Granzymes</subject><subject>Humans</subject><subject>Killer Cells, Lymphokine-Activated - immunology</subject><subject>Killer Cells, Lymphokine-Activated - pathology</subject><subject>Killer Cells, Natural - immunology</subject><subject>Killer Cells, Natural - pathology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - immunology</subject><subject>Serine Endopeptidases - pharmacology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EKkvhBZCQfOKWxfY6TnyECiiiggucrdl4vHHrxMFOuuwb8Zj1tgs9cvJY_uYfz_8T8pqztWRSv7v2w7CMMax5rdd8zYV6Qla8rlmlFFNPyYoxISreqOY5eZHzNWNMMSHPyJkWjEnZrMifD12oBMXfU8KcfRypH-kMaYcz7TCETAOCzXSO1C1jNxcCQmF6v_XHC42OdpAnyFht6JTijKWkDgYfDketfhlgpN--UhgtDYdh6uONH7GConULM1p640PAdD-N7hKMS8BqQOvvH2GK0xyzzy_JMwch46vTeU5-fvr44-Kyuvr--cvF-6uqK5bMVV23CkUrrWqZdKA7UTcbaVsBICXXCrdWArdWOi1A2S3XunFotegcctXozTl5-6Bbdvm1YJ7N4PPxbzBiXLJpNGuU5v8HebG6ZS0voHgAuxRzTujMlPwA6WA4M8cczd8cTcnRcFNyLE1vTurLtpjxr-UU3OP03u_6vU9o8gAhFJqb_X7_KHQHfK-sOA</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>Renvoize, C</creator><creator>Roger, R</creator><creator>Moulian, N</creator><creator>Bertoglio, J</creator><creator>Breard, J</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis</title><author>Renvoize, C ; Roger, R ; Moulian, N ; Bertoglio, J ; Breard, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-5586e284d6804fa9c25734d82aa44196ebd4a1dd4f92a6db1997fed92cfe16793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Apoptosis - drug effects</topic><topic>Apoptosis - genetics</topic><topic>Apoptosis - immunology</topic><topic>Caspase 3</topic><topic>Caspases</topic><topic>Cell Line</topic><topic>Cysteine Endopeptidases - genetics</topic><topic>Cysteine Endopeptidases - immunology</topic><topic>Cytoplasmic Granules - pathology</topic><topic>Exocytosis - drug effects</topic><topic>Gene Expression Regulation</topic><topic>Gene Transfer Techniques</topic><topic>Granzymes</topic><topic>Humans</topic><topic>Killer Cells, Lymphokine-Activated - immunology</topic><topic>Killer Cells, Lymphokine-Activated - pathology</topic><topic>Killer Cells, Natural - immunology</topic><topic>Killer Cells, Natural - pathology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - immunology</topic><topic>Serine Endopeptidases - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Renvoize, C</creatorcontrib><creatorcontrib>Roger, R</creatorcontrib><creatorcontrib>Moulian, N</creatorcontrib><creatorcontrib>Bertoglio, J</creatorcontrib><creatorcontrib>Breard, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Renvoize, C</au><au>Roger, R</au><au>Moulian, N</au><au>Bertoglio, J</au><au>Breard, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>159</volume><issue>1</issue><spage>126</spage><epage>134</epage><pages>126-134</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>In the granule exocytosis pathway of cell-mediated cytotoxicity, rapid apoptotic nuclear damage in target cells has been unequivocally linked to granzyme B activity. Direct cleavage and activation of caspase-3 and related proteases by granzyme B have been identified as a central event in apoptosis induction by cytotoxic granules. The Bcl-2 oncoprotein has been recently shown to act at the level or upstream of caspase-3 family activation to inhibit apoptosis induced by various stimuli including Fas ligation, an alternative cell-mediated lytic pathway. In this study, we have investigated whether activation of this caspase family by granzyme B, during human NK and lymphokine-activated killer cell granule-mediated apoptosis, could be influenced by Bcl-2 expression. Bcl-2-overexpressing clones were generated from parental K562 and U937 cell lines (K6 and U4 clones, respectively). Bcl-2 expression abrogated early 125I-DNA release and DNA fragmentation, these defects being compensated for by extended incubation times. Cleavage of poly(ADP-ribose) polymerase, a specific caspase-3 family substrate, was detected in parental K562 cells exposed to lymphokine-activated killer effectors but not in K6 targets, indicating that caspase-3 and related proteases function was inhibited by Bcl-2. Functional inhibition of caspase-3 family with benzyloxycarbonyl-Asp-Glu-Val-Asp(OMe) fluoromethylketone led to similar consequences on apoptotic nuclear events as for Bcl-2 expression. Thus, Bcl-2 antagonizes granzyme B-mediated apoptosis by a mechanism that interferes with caspase-3 activity. Finally, Bcl-2 expression or the Asp-Glu-Val-Asp peptide was much less efficient in preventing phosphatidylserine externalization, suggesting that despite impaired nuclear apoptosis, immediate recognition and elimination of Bcl-2-expressing cells by tissue phagocytes should remain partly unaffected.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>9200447</pmid><doi>10.4049/jimmunol.159.1.126</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 1997-07, Vol.159 (1), p.126-134
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_79076919
source MEDLINE; Alma/SFX Local Collection
subjects Apoptosis - drug effects
Apoptosis - genetics
Apoptosis - immunology
Caspase 3
Caspases
Cell Line
Cysteine Endopeptidases - genetics
Cysteine Endopeptidases - immunology
Cytoplasmic Granules - pathology
Exocytosis - drug effects
Gene Expression Regulation
Gene Transfer Techniques
Granzymes
Humans
Killer Cells, Lymphokine-Activated - immunology
Killer Cells, Lymphokine-Activated - pathology
Killer Cells, Natural - immunology
Killer Cells, Natural - pathology
Proto-Oncogene Proteins c-bcl-2 - genetics
Proto-Oncogene Proteins c-bcl-2 - immunology
Serine Endopeptidases - pharmacology
title Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T15%3A30%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bcl-2%20expression%20in%20target%20cells%20leads%20to%20functional%20inhibition%20of%20caspase-3%20protease%20family%20in%20human%20NK%20and%20lymphokine-activated%20killer%20cell%20granule-mediated%20apoptosis&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Renvoize,%20C&rft.date=1997-07-01&rft.volume=159&rft.issue=1&rft.spage=126&rft.epage=134&rft.pages=126-134&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.159.1.126&rft_dat=%3Cproquest_cross%3E16028081%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16028081&rft_id=info:pmid/9200447&rfr_iscdi=true